Frequency of hepatorenal syndrome among cirrhotics

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 10, 2005, Pages 590-593

  Kumar, Raj ^a   Ahmed, Raeefuddin ^a,b   Rathi, Suresh Kumar ^a   Sethar, Gul Hassan ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b 96 BYJ Society   (Pakistan)

Author keywords

Ascites; Chronic liver disease; Cirrhosis; Hepatorenal syndrome

Indexed keywords

CREATININE; DIURETIC AGENT; SODIUM CHLORIDE;

ANALGESIC NEPHROPATHY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FREQUENCY ANALYSIS; HEALTH CARE FACILITY; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPOVOLEMIA; INFUSION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PAKISTAN; PATIENT IDENTIFICATION; PREVALENCE; PROTEIN URINE LEVEL; SEX RATIO; TREATMENT WITHDRAWAL; ULTRASOUND; URINALYSIS; URINARY EXCRETION; WARD;

ADULT; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HEPATORENAL SYNDROME; HUMANS; LIVER CIRRHOSIS; MALE; PAKISTAN; PREVALENCE;

EID: 31744444103     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kreige J, Beckingham J. ABC of diseases of liver, pancreas and biliary system. BMJ 2001; 322: 416-8.
2. Koppel M, Coburn J, Mins M. Transplantation of cadaveric kidneys from patients with functional renal failure in advanced liver disease. N Engl J Med 1996; 289: 1155-7.
3. Bataller R, Arroyo V, Gines P, Sort P. Hepatorenal syndrome. Forum (Geneva) 1998; 8: 62-81.
4. Bataller R, Gines P, Arroyo V. Practical recommendations for the treatment of ascites and its complications. Drugs 1997; 54: 571-80.
5. Kramer L, Hori W. Hepatorenal syndrome. Semin Nephrol 2002; 40: 290-301.
6. Gines P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol 1999; 10: 1833-9.
7. Gentilini P, Laffi G, La vill G, Raggi V. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Ann Ital Med Int 1999; 14: 264-84.
8. Moreau R, Lebrec D. Hepatorenal syndrome-definitions and diagnosis. Aliment Pharmacol Ther 2004; 20 (suppl 3):24-8.
9. Arroyo V, Gines P, Gerbes A, Dudley F, Gentilini P. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996, 23: 164-76.
10. Gines P, Torre A, Terra C, Guevara M. Pharmacological treatment of hepatorenal syndrome. Aliment Pharmacol Ther 2004; 20 (suppl 3): 57-62.
11. Angeli P. Prognosis of hepatorenal syndrome - has it changed with current practice? Aliment Pharmacol Ther 2004; 20 (suppl 3): 44-6.
12. Arroyo V. Hepatorenal syndrome-how to assess response to treatment and non-pharmacological therapy. Aliment Pharmacol Ther 2004; 20 (suppl 3): 49-54.
13. Khokhar N, Gill M, Malik G. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 534-6.
14. Asif N, Khokhar N, Ilahi F. Seroprevalence of HBV, HCV and HIV infection among voluntary non-remunerated and replacement donors in northern Pakistan. Pak J Med Sci 2004; 20: 24-8.
15. Mashud I, Khan H, Khattak A. Relative frequency of hepatitis B and C viruses in patients with hepatic cirrhosis at DHQ Teaching Hospital, D.I. Khan. J Ayub Med Coll (Abottabad) 2004; 16: 32-4.
16. Khokhar N, Niazi S. Chronic liver disease related mortality pattern in northern Pakistan. J Coll Physicians Surg Pak 2003; 13: 495-7.
17. Gines A, Escorsell A, Gines P. Incidence, predictive factors and prognosis of hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-36.
18. Gines P, Martin P, Neiderberger M. Prognostic significance of renal dysfunction in cirrhosis. Kidney Int 1997; 51: 577-84.
19. Follo A, Llovet J, Navasa M. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients with cefotaxime. Hepatology 1994; 20: 1495-1501.